A re-evaluation of LINE-1 ORF2 expression in LNCaP prostate cancer cells.

Mob DNA

1Departments of Biochemistry and Molecular Pharmacology, New York University School of Medicine, Alexandria Center for Life Sciences, 450 East 29th Street, Room 323, New York, NY 10016 USA.

Published: December 2019

AI Article Synopsis

Article Abstract

Background: We previously examined expression of Long Interspersed Element-1 (LINE-1) in a variety of prostate cancer cells including hormone-dependent LNCaP cells. These studies demonstrated expression and sub-cellular localization of LINE-1 proteins, ORF1p, with antibody 4H1, and ORF2p, with antibody chA1-L1.

Results: Here we conduct immunoprecipitation/mass spectrometry analysis using chA1-L1 antibody against ORF2p in LNCaP cells. Our results indicate that antigens detected by the antibody include the transcriptional regulator BCLAF1. We show that chA1-L1 recognizes BCLAF1 using siRNA knockdown and overexpression of a tagged BCLAF1. We also show that chA1-L1 antibody recognizes ORF2p in HEK293 cells overexpressing LINE-1. Further, analysis of ORF2p (chA1-L1) and BCLAF1 foci using immunofluorescence in LNCaP cells showed significant colocalization.

Conclusions: Overall, our findings indicate that chA1-L1 antibody recognizes both BCLAF1 and ORF2p but the majority of antigen recognized in LNCaP cells is BCLAF1.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6935485PMC
http://dx.doi.org/10.1186/s13100-019-0196-xDOI Listing

Publication Analysis

Top Keywords

lncap cells
16
cha1-l1 antibody
12
prostate cancer
8
cancer cells
8
bclaf1 cha1-l1
8
recognizes bclaf1
8
antibody recognizes
8
cells
7
antibody
6
bclaf1
6

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!